Boardroom Alpha
Boardroom Alpha
BALY · Additional Proxy Materials (DEFA14A) · Filed May 8, 2026

Bally's Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
May 8, 2026
Ticker
BALY
Accession
0001747079-26-000037
Boardroom Alpha · Filing insights

Bally’s Corporation adds Pay Versus Performance section in proxy supplement; discloses 2025 compensation and TSR context.

About Bally's Corp
Market cap
$662M
1Y TSR
+30.8%
3Y TSR
−5.9%
Board grade
D
Sector
Consumer Cyclical
CEO
Robeson Reeves
Last annual meeting: May 19, 2026 · View full Bally's Corp profile →
baly-20260508

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No.)
Filed by the Registrant ☒
Filed by a party other than the Registrant
Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under §240.14a-12
BALLY’S CORPORATION
(Name of Registrant as Specified In Its Charter)
   
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
 ☒No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.



blys_lg_rgb_pos_210420.jpg
Supplement to the Definitive Proxy Statement
for the 2026 Annual Meeting of Shareholders
To be Held on Thursday, May 19, 2026

EXPLANATORY NOTE

This proxy statement supplement (the “Supplement”) supplements and amends the definitive proxy statement on Schedule 14A (the “Proxy Statement”) filed with the Securities and Exchange Commission by Bally’s Corporation (the “Company”) on April 9, 2026.

The Proxy Statement inadvertently omitted the “Pay Versus Performance” section. This Supplement is being filed to add the “Pay Versus Performance” section following the “Equity Compensation Plan Information” section on page 25 of the Proxy Statement. This additional information is provided below.

Except as specifically discussed in this Explanatory Note, this Supplement does not otherwise modify or update any other disclosures presented in the Proxy Statement. This Supplement should be read with the Proxy Statement, and, from and after the date of this Supplement, any references to the “Proxy Statement” shall be deemed to include the Proxy Statement as amended by this Supplement.

If you have already voted by Internet, telephone, or by mail, you do not need to take any action unless you wish to change your vote. Proxy voting instructions already returned by stockholders (via Internet, telephone, or mail) will remain valid and will be voted at the Annual Meeting unless revoked. Important information regarding how to vote your shares and revoke proxies already cast is available in the Proxy Statement under the caption “General Information About the Annual Meeting and Voting.”



Pay Versus Performance
YearRobeson ReevesLee Fenton
Average
Summary
Compensation
Table Total
for Non‑PEO
Named
Executive
Officers(1)
Average Compensation Actually Paid to Non‑PEO Named Executive Officers (2)
Summary Compensation Table Total for PEO (1)
Compensation Actually Paid to PEO (2)
Summary Compensation Table Total for PEO (1)
Compensation Actually Paid to PEO (2)
2025$8,658,602 $11,034,926 $— $— $2,939,944 $3,282,825 
2024$2,290,759 $2,987,926 $— $— $1,329,282 $1,584,671 
2023$4,537,197 $3,609,523 $1,571,215 $851,126 $1,814,783 $1,427,000 
Value of Initial Fixed $100 Investment Based On Total Shareholder Return (3)
Net Income (Loss)(4) (in thousands)
202585.24$(701,098)
202495.30$(567,754)
202371.93$(187,500)

(1) Mr. Reeves was our principal executive officer (“PEO”) from March 31, 2023 through December 31, 2023 and for the full years of 2024 and 2025. Mr. Fenton was our PEO from January 1, 2023 through March 31, 2023. For 2025, our non-PEO named executive officers (“Non-PEO NEOs”) were Ms. Barker, Mr. Papanier, and former executive Marcus Glover. For 2024, our Non-PEO NEOs were Ms. Barker and Messrs. Eaton and Papanier, and former executive Marcus Glover. For 2023, our Non-PEO NEOs were Ms. Barker and Messrs. Eaton and Papanier, and former executives Marcus Glover and Robert Lavan.

(2)    For 2025 (the “Covered Year”), the values included in this column for the compensation actually paid to our PEO and the average compensation actually paid to our Non-PEO NEOs for purposes of this Pay Versus Performance table (“PVP Table”):
Compensation Actually Paid represents the Summary Compensation Table Totals adjusted for the following items:2025
For Robeson Reeves:
Less Summary Compensation Table “Stock Awards” value$(590,012)
Less Summary Compensation Table “Option Awards” value(5,003,460)
Plus year-end fair value of outstanding equity awards granted in Covered Year that are outstanding and unvested as of the Covered Year-end7,717,305 
Change in fair value (from prior year-end to Covered Year-end) of equity awards granted in prior years that are outstanding and unvested as of the Covered Year-end(48,928)
Plus vesting date fair value of equity awards granted and vested in Covered Year343,830 
Change in fair value (from prior year-end to vesting date) of equity awards granted in prior years that vested in Covered Year2,869 
Less fair value as of prior year-end equity awards that failed to vest in the Covered Year(45,280)
Plus dollar value of dividends/earnings paid on equity awards during Covered Year— 
For Non-PEO NEOs (Average):
Less Summary Compensation Table “Stock Awards” value$(332,768)
Less Summary Compensation Table “Option Awards” value(1,111,880)
Plus year-end fair value of outstanding equity awards granted in Covered Year that are outstanding and unvested as of the Covered Year-end1,825,575 
Change in fair value (from prior year-end to Covered Year-end) of equity awards granted in prior years that are outstanding and unvested as of the Covered Year-end(20,047)
Plus vesting date fair value of equity awards granted and vested in Covered Year— 
Change in fair value (from prior year-end to vesting date) of equity awards granted in prior years that vested in Covered Year(17,999)
Less fair value as of prior year-end equity awards that failed to vest in the Covered Year— 
Plus dollar value of dividends/earnings paid on equity awards during Covered Year— 




(3)    For each Covered Year, our total shareholder return was calculated as the yearly percentage change in our cumulative total shareholder return on our common shares, par value $0.01 per share, measured as the quotient of (a) the sum of (i) the cumulative amount of dividends for a period beginning with our closing price on NYSE on December 30, 2022 through and including the last day of the fiscal year covered (the “Measurement Period”), assuming dividend reinvestment, plus (ii) the difference between our closing stock price at the end versus the beginning of the Measurement Period, divided by (b) our closing share price at the beginning of the Measurement Period. Each of these yearly percentage changes was then applied to a deemed fixed investment of $100 at the beginning of the Measurement Period to produce the Covered Year-end values of such investment as of the end of 2025, 2024 and 2023, as applicable. Because Covered Years are presented in the table in reverse chronological order (from top to bottom), the table should be read from bottom to top for purposes of understanding cumulative returns over time.
(4)    Amounts represent net income reflected in the Company’s audited financial statements for the applicable year and is calculated in accordance with U.S. Generally Accepted Accounting Principles. For 2025, net income represents the sum of net income for the Predecessor period (from January 1, 2025 to February 7, 2025) and for the Successor period (from February 8, 2025 to December 31, 2025) of $51.0 million and $650.1 million, respectively.









The following graphical comparisons provide descriptions of the relationships of the compensation actually paid to the PEO and the average of the compensation actually paid to our Non-PEO NEOs (in each case as set forth in the PVP table above) to (1) our cumulative total shareholder return, and (2) the performance measure Net Income (Loss), each as set forth in the PVP Table above.

644
646




From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Bally's Corp (BALY)

Reference

Frequently asked questions

When did Bally's Corp file this DEFA14A?
Bally's Corp (BALY) filed this Additional Proxy Materials (DEFA14A) with the SEC on May 8, 2026. The accession number assigned by EDGAR is 0001747079-26-000037.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Bally’s Corporation adds Pay Versus Performance section in proxy supplement; discloses 2025 compensation and TSR context. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Bally's Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Bally's Corp has filed under CIK 1747079, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer